American Vanguard (AVJ) Q2 2026 Earnings Report

The call presents a mixed picture: significant operational progress (H1 gross margin improvement, >20% YTD adjusted EBITDA growth, specialty segment strength, R&D investment and announced cost savings) and clear strategic targets for 2026–2028. However, Q2 was notably weaker with a meaningful revenue decline, a steep drop in quarterly adjusted EBITDA, freight-driven margin headwinds, international softness, lower cash and higher net debt. Management emphasizes control of costs, pricing actions, and near-term initiatives to improve operating leverage and expects full-year targets to be met, which tempers the near-term negatives.

Management reiterated 2026 guidance of $44–$48 million of adjusted EBITDA on $530–$550 million of sales, and said it expects to reach an annualized run rate north of $600 million by the back half of 2028 (about 20% above 2025) with a goal of double‑digit EBITDA margins; near‑term actions include LA plant rationalization to save at least $4 million annualized and pricing to recover freight headwinds (~$2.2M, ~90 bps YTD). Key reported metrics: Q2 sales $117M (vs. $129M a year ago), H1 sales $240M (down ~2% YoY), Q2 adjusted EBITDA $0.6M (vs. $11M prior) while H1 adjusted EBITDA rose to $17M (+>20% YoY), H1 gross margin improved 100 bps to 30% (Q2 GM 30% vs. 31% prior). Business mix and geography: US sales +6% H1 (US crop +5% H1, specialty +10% H1; specialty +11% in Q2), international sales -18% in Q2 and -13% H1; inventories $181M (vs. $191M prior year), cash $43.9M quarter‑end, total debt ~$267.6M and net debt ~$224.7M, and R&D investment up 12% YoY with a target of 50 new product launches over five years to drive $100M of annualized revenue by 2030.